Eastman Kodak's CEO is defending the company's handling of a now halted $765 million pharmaceutical deal.
Jim Continenza told the Wall Street Journal that the company will make drug ingredients with or without the federal loan.
The deal was put on hold because of stock options acquired by Kodak executives and a media leak before the deal was announced. A special committee appointed by Kodak's board found there were no violations of the law.
The U.S. government continues its investigation into the deal.
"ingredients" - Google News
October 21, 2020 at 03:27AM
https://ift.tt/35pJQrE
Kodak Will Make Drug Ingredients With or Without Fed. Loan - Spectrum News
"ingredients" - Google News
https://ift.tt/2Qstat1
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "Kodak Will Make Drug Ingredients With or Without Fed. Loan - Spectrum News"
Post a Comment